Science & Enterprise subscription

Follow us on Twitter

  • Researchers from University of California in Los Angeles and Apple Corp. are beginning a study of wearable and home… https://t.co/ICUkzqP2sH
    about 2 hours ago
  • New post on Science and Enterprise: UCLA, Apple Partner on Depression Study https://t.co/6JcVfww7FT #Science #Business
    about 2 hours ago
  • A new company developing treatments to relieve allergic reactions with reprogrammed antibodies began work and is ra… https://t.co/LFNVxych8d
    about 8 hours ago
  • New post on Science and Enterprise: New Allergy Biotech Launches, Raises $10M https://t.co/x5W0TwnCBu #Science #Business
    about 8 hours ago
  • Two companies and NIH are beginning a clinical trial of synthetic antibodies to both treat and prevent Covid-19 inf… https://t.co/LaUrUiRmhk
    about 1 day ago

Please share Science & Enterprise

Infographic – Security Top A.I. Application

Leading A.I. uses 2018

Click on image for full-size view (Statista.com)

6 Apr. 2019. As more businesses implement artificial intelligence or A.I., in their operations, boosting security is emerging as the leading way to use this technology. Our friends at Statista reported these findings yesterday in chart form, and it’s our infographic for this weekend.

Data for the chart come from a survey done last year for Consumer Technology Association, available for purchase from Statista, showing detection of security threats is the leading A.I. use, by more than 4 in 10 respondents worldwide. Nearly as many respondents (41%) say they use A.I. to help resolve customers’ technical questions, while about 1 in 3 each (34%) cite automating product management and tracking internal rules compliance as leading applications.

The data indicate companies are using various forms of A.I., such as voice recognition and natural language processing — technologies used in chatbots, for example — as well as machine learning. Most A.I. uses noted in Science & Enterprise are for scientific or medical decision making, such as in diagnostics, genomic analysis, and drug discovery, as cited in the links to recent stories below.

More from Science & Enterprise:

*     *     *

Comments are closed.